Chloramphenicol succinate

Overview

Chloramphenicol succinate is a prodrug of Chloramphenicol ( HY-B0239 ), acting as a P2Y14R inhibitor with an IC 50 of 1.585 nM. Chloramphenicol succinate serves as a competitive substrate and inhibitor of succinate dehydrogenase (SDH), which may account for its toxicity. Chloramphenicol succinate exerts a significant inhibitory effect on colitis. Chloramphenicol succinate can be used in research related to myelosuppression, gray baby syndrome, aplastic anemia, bacterial meningitis and inflammatory bowel disease.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > P2Y Receptor | Products > Signaling Pathways > Drug Intermediate | Products > Signaling Pathways > Succinate Dehydrogenase

Product Information

• Catalog No.: HY-N7114
• CAS No.: 3544-94-3
• Molecular Formula: C15H16Cl2N2O8
• Molecular Weight: 423.20
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source